Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Kevin Lee Freeman is Chief Commercial Officer at Health Catalyst. OQRO lists 2 transactions filed with the SEC under this name, the latest on Dec 4, 2025, each linked to the official Form 4.
Chief Commercial Officer
Disclosures on record
2
Companies involved
1
Kevin Lee Freeman has no open-market purchase on record since 2024. Sales in 1 of the 3 years since 2024.
Kevin Lee Freeman reported 0 open-market purchases and 3 sales since 2024; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2024 | — | $170K3×3 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Kevin Lee Freeman reported 0 open-market purchases and 3 sales here, 2024.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
Health CatalystHCAT
2 disclosures · Dec 2024 – Dec 2025 · 1 sold
Dec 1, 202516Kdisclosed Dec 4
DetailsOfficial recordDec 2, 2024Sold~$67Kdisclosed Dec 3
DetailsOfficial recordAs of the latest filing on , Kevin Lee Freeman reported holding 358,686 shares of Health Catalyst (HCAT), worth about $542K at the last close of $2 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Health Catalyst HCAT | 358,686 | 359K direct | $2 | $542K | Dec 1, 2025 |
Is this Kevin Lee Freeman’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Dec 1, 2025, Kevin Lee Freeman reported holding 358,686 shares of Health Catalyst (HCAT). At the last close of $2 on Nov 13, 2026, that is about $542K. This is the stake disclosed in filings, not a net worth.
Kevin Lee Freeman has no open-market purchase on record since 2024. Sales in 1 of the 3 years since 2024.
In SEC filings since 2024: no open-market purchase is on record; the latest open-market sale is from 2024.
Health Catalyst (HCAT), from 2024 to 2024: 0 purchases and 3 sales.
